BioWorld

June 22, 1999

View Archived Issues

Other News To Note

Read More

Appointments And Advancements

Read More

MSSI's Test For CAD Shows Ability To Identify High Risks

Read More

Chimeric's Transplant Technology Moves Into Pivotal GVHD Study

Read More

Immune Response Cuts Staff After Setback Of HIV Product

Read More

Monoclonal, In Phase I/II Trial Of Uveitis, Equaled Standard Therapy Without Horrendous Side Effects

Read More